XML 72 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
 12 Months Ended
Nov. 29, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Assumptions Used to Value Employee Stock Purchase Rights
The expected term of ESPP shares is the average of the remaining purchase periods under each offering period. The assumptions used to value employee stock purchase rights were as follows:
 
2019
 
2018
 
2017
Expected life (in years)
0.5 - 2.0
 
0.5 - 2.0
 
0.5 - 2.0
Volatility
30% - 35%
 
26% - 29%
 
22% - 27%
Risk free interest rate
1.78% - 2.47%
 
1.54% - 2.52%
 
0.62% - 1.41%
 
Restricted Stock Unit Activity
Restricted stock unit activity for fiscal 2019, 2018 and 2017 was as follows:
  (in thousands)
2019
 
2018
 
2017
Beginning outstanding balance
8,668

 
9,304

 
8,316

Awarded
4,598

 
4,012

 
5,018

Released
(3,847
)
 
(3,988
)
 
(3,859
)
Forfeited
(785
)
 
(660
)
 
(766
)
Increase due to acquisition
—

 
—

 
595

Ending outstanding balance
8,634

 
8,668

 
9,304
Restricted Stock Units Outstanding
Information regarding restricted stock units outstanding at November 29, 2019, November 30, 2018 and December 1, 2017 is summarized below:
 
Number of
Shares
(thousands)
 
Weighted
Average
Remaining
Contractual
Life
(years)
 
Aggregate
Intrinsic
Value(*)
(millions)
2019
 
 
 
 
 
Restricted stock units outstanding
8,634

 
1.12
 
$
2,672.6

Restricted stock units expected to vest
7,987

 
1.05
 
$
2,472.2

2018
 

 
 
 
 

Restricted stock units outstanding
8,668

 
1.06
 
$
2,174.7

Restricted stock units expected to vest
8,049

 
1.01
 
$
2,019.5

2017
 
 
 
 
 
Restricted stock units outstanding
9,304

 
1.11
 
$
1,670.2

Restricted stock units expected to vest
8,608

 
1.05
 
$
1,545.3

_________________________________________ 
(*) 
The intrinsic value is calculated as the market value as of the end of the fiscal period. As reported by the NASDAQ Global Select Market, the market values as of November 29, 2019, November 30, 2018 and December 1, 2017 were $309.53, $250.89 and $179.52, respectively.
Performance Share Activity
Performance share activity for fiscal 2019, 2018 and 2017 was as follows: 
 (in thousands)
2019
 
2018
 
2017
 
Shares
Granted (1)
 
Maximum
Shares Eligible
to Receive
 
Shares
Granted (2)
 
Maximum
Shares Eligible
to Receive
 
Shares
Granted (3)
 
Maximum
Shares Eligible
to Receive
Beginning outstanding balance
1,148

 
2,296

 
1,534

 
3,068

 
1,630

 
3,261

Awarded
722

 
614

 
837

 
628

 
1,082

 
1,040

Achieved
(830
)
 
(830
)
 
(1,050
)
 
(1,053
)
 
(1,135
)
 
(1,147
)
Forfeited
(82
)
 
(164
)
 
(173
)
 
(347
)
 
(43
)
 
(86
)
Ending outstanding balance
958

 
1,916

 
1,148

 
2,296

 
1,534

 
3,068


_________________________________________ 
(1) 
Shares awarded during fiscal 2019 include 0.4 million additional shares awarded for the final achievement of the 2016 Performance Share Program which was certified in the first quarter of fiscal 2019. The remaining awarded shares were for the 2019 Performance Share Program. Shares achieved during fiscal 2019 resulted from 200% achievement of target for the 2016 Performance Share Program.
(2) 
Shares awarded during fiscal 2018 include 0.5 million additional shares awarded for the final achievement of the 2015 Performance Share Program which was certified in the first quarter of fiscal 2018. The remaining awarded shares were for the 2018 Performance Share Program. Shares achieved during fiscal 2018 resulted from 200% achievement of target for the 2015 Performance Share Program.
(3) 
Shares awarded during fiscal 2017 include 0.6 million additional shares awarded for the final achievement of the 2014 Performance Share Program which was certified in the first quarter of fiscal 2017. The remaining awarded shares were for the 2017 Performance Share Program. Shares achieved during fiscal 2017 resulted from 198% achievement of target for the 2014 Performance Share Program.
Restricted Stock Units Granted to Directors
Restricted stock units granted to directors for fiscal 2019, 2018 and 2017 were as follows:
  (in thousands)
2019
 
2018
 
2017
Annual equity grants to existing directors
10

 
11

 
18

Initial equity grants to new directors
1

 
1

 
—
Total Stock-Based Compensation Costs
Total stock-based compensation costs that have been included in our Consolidated Statements of Income for fiscal 2019, 2018 and 2017 were as follows:
  (in thousands)
  Income Statement Classifications
 
Cost of
Revenue–
Subscription
 
Cost of
Revenue–
Services and Support
 
Research and Development
 
Sales and
Marketing
 
General and Administrative
 
 
Total (1)
Restricted Stock Units and Performance
Share Awards
 

 
 

 
 

 
 

 
 

 
 

2019
$
22,822

 
$
18,535

 
$
338,483

 
$
206,371

 
$
98,886

 
$
685,097

2018
$
17,515

 
$
12,111

 
$
253,078

 
$
178,548

 
$
77,462

 
$
538,714

2017
$
16,792

 
$
9,602

 
$
161,366

 
$
139,047

 
$
77,133

 
$
403,940

Stock Purchase Rights and Options
 
 
 
 
 
 
 
 
 
 
 
2019
$
5,823

 
$
7,271

 
$
36,663

 
$
42,405

 
$
10,446

 
$
102,608

2018
$
4,102

 
$
8,286

 
$
23,918

 
$
27,252

 
$
7,290

 
$
70,848

2017
$
180

 
$
6,661

 
$
20,126

 
$
18,592

 
$
4,973

 
$
50,532

_________________________________________ 
(1) 
During fiscal 2019, 2018 and 2017, we recorded tax benefits related to stock-based compensation costs of $248.4 million, $222.4 million and $153.2 million, respectively.